Commercial evidence
What does the customer interest establish?
Twelve organizations have acknowledged non-binding letters of intent. The evidence supports the next commercial step: negotiating scoped, paid pilots.
Request diligence accessInside this chapter
Non-binding expressions of interest; not signed customer contracts or revenue.
Source: letter packet reviewed page by page, October 1, 2026. The packet contains 15 letters addressed to 14 organizations. One organization received a second letter.
The evidence, and the next commercial decision.
What is documented
- Twelve healthcare organizations acknowledged non-binding letters.
- The packet records the recipient, acknowledgement and historical proposal.
- Original letters and organization names are available in confidential diligence.
What has to be earned next
- A named pilot buyer and an agreed workflow scope.
- A signed paid agreement with the necessary data permissions.
- A measured operating result the facility is willing to pay to continue.
Rōvn is pre-revenue with no paying customer or signed pilot, as recorded October 1, 2026.
Interest across healthcare employers.
The acknowledged letters span health systems, specialty practices, behavioral health, telehealth and senior living.
The original letters and organization names are available confidentially in diligence. The next step is an agreed deployment scope and a signed pilot.
Request diligence access →From interest to operating evidence.
- Interest documented
- Acknowledged letters provide a starting point for a direct deployment conversation with each organization.
- Scope agreed
- Confirm the buyer, workflow, decision owners, data permissions and commercial terms in a separate pilot agreement.
- Value measured
- Establish the facility’s baseline, run the agreed work and put the operating result in front of its finance lead.
How the current pilot differs from the letters
The historical letters described a 90-day founding pilot at $2,500 a month. The current plan is a paid 180-day pilot at $30 per certified bed per month, prepaid.
The current plan does not amend those letters or create a payment obligation. Pricing for organizations without certified beds remains to be set.
Current plan, October 1, 2026. Pilot design and measurement.
Count the organization, the document and the decision separately.
The packet contains 15 letters to 14 organizations because one organization received a second letter. Twelve organizations acknowledged a non-binding letter; three letters remain unacknowledged. Those categories are deliberately kept separate so document volume is not mistaken for distinct committed customers.
An acknowledgement supports the claim that the organization engaged with the proposal. It does not establish that the recipient can sign the current commercial terms, that a site has completed deployment requirements, or that money has changed hands. The next conversation must confirm the current buyer, applicable workflow and agreement.
The category breadth is useful for discovery: different healthcare employers may experience related coordination problems. It also creates qualification work. A specialty practice and a certified-bed facility may need different source routes, workflow scopes and commercial units. One proposal cannot be assumed to fit them all.
Define the evidence needed to move forward.
- Acknowledged interest
- Retain the original proposal and acknowledgement, dated and deduplicated by organization. This is the stage documented by the current letter packet.
- Qualified scope
- Record the sponsor, buying authority, proposed workflow, source routes and unresolved prerequisites. Qualification is a next-step assessment, not a signed order.
- Contracted pilot
- Retain the executed agreement, commercial unit, term, scope and data permissions. Track the contract and any actual payment separately.
- Activated operation
- Identify the eligible site and cohort, accepted baseline and completed activation requirements. A signed agreement alone does not prove that work is running.
- Accepted result
- Show a completed case with its source evidence, required decisions, destination acceptance and full effort record. An internal demo or sent message cannot substitute for it.
- Paid continuation
- Show the finance-reviewed result and a separate decision to continue. Repeat use, renewal and expansion need their own dated evidence.
Future reporting should keep the full set of eligible prospects and cases visible at each step, including stalled or lost ones. That makes conversion and completion rates interpretable. This room does not infer those rates from the current letter count.
Make customer learning specific enough to change the product.
A useful discovery record identifies the workflow the customer actually performs: the triggering event, systems used, required documents, repeated requests, wait states and decision owners. It distinguishes what the buyer says is painful from what a walkthrough or source record confirms.
For each proposed improvement, the team should be able to show which observed problem it addresses and how a facility would judge the result. If the customer disputes the operating map, that disagreement becomes an unresolved requirement. If the problem is too infrequent or inexpensive to justify the price, it changes qualification or scope.
We are not using an unsupported interview count or a manufactured customer quote as proof. The current public commercial claim is the acknowledged letter record. The next layer of evidence is an owner-accepted operating map and a signed baseline in a real pilot.
What an investor can examine in diligence.
The confidential letter packet allows a reviewer to inspect the original proposals, recipients, dates and acknowledgements. Historical terms should be compared with the current pricing plan; a later founder plan does not amend an earlier letter.
The next diligence questions are concrete: who can approve the pilot, what workflow is being purchased, which requirements remain open, what the buyer will measure and who accepts the result. Where an answer or artifact is not yet available, it remains an open item rather than being filled with a confident summary.
Names, correspondence and private pipeline detail remain in the access-controlled process. The public room provides the argument and its qualifications; the permitted source materials let an investor examine the underlying record.
Request access to the supporting material →